How to Screen for Diabetic Polyneuropathy: What You Need to Know

Published: Jan 07, 2024

Screening for diabetic polyneuropathy is crucial for early intervention and prevention of complications.

Who Needs Screening?

All patients with type 2 diabetes should be screened at diagnosis, while type 1 diabetes patients need screening five years after diagnosis. Those with prediabetes and symptoms should also be screened. Annual screening is recommended for those without symptoms to catch any developments early.

Essential Screening Steps

Screening involves a detailed history and physical examination to assess nerve function. Tests include checking sensitivity to light touch and vibration, and evaluating reflexes. These steps help identify early signs of neuropathy before severe symptoms develop.

Diabetic polyneuropathy is a complication of diabetes that affects the peripheral nerves, leading to loss of sensation and sometimes pain.

Simple Screening Tools

Several tools, like the Michigan Neuropathy Screening Instrument, offer quick assessments. These tools evaluate symptoms and physical signs, assisting healthcare professionals in diagnosing diabetic polyneuropathy efficiently. Early detection can lead to better management and reduced complications.

Frequently Asked Questions

Five years after diagnosis.

Tests for light touch, vibration sensitivity, and reflexes are key.

It helps catch neuropathy developments early.

A tool for assessing symptoms and signs of neuropathy.

Key Takeaways

Regular screening can significantly impact the management of diabetic polyneuropathy.

Discuss screening options for diabetic polyneuropathy with Doctronic today.

Related Articles

References

Herman WH, Pop-Busui R, Braffett BH, et al. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. Diabet Med 2012; 29:937.

Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017; 40:136.

Always discuss health information with your healthcare provider.